Superior Planning, LLC’s Tandem Diabetes Care TNDM Stock Holding History

Superior Planning, LLC’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.18K	Buy	+134	New	+$2.52K	﹤0.01%	1532

Other funds holding TNDM

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Superior Planning, LLC's TNDM Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Tandem Diabetes Care (TNDM) in Q3 2026: 134 shares worth $2.18K. The stake represents ﹤0.01% of the portfolio and ranks #1532 among its holdings.

162 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

Superior Planning, LLC held 134 shares of Tandem Diabetes Care worth $2.18K as of Q3 2026.
Tandem Diabetes Care was a new Superior Planning, LLC position in Q3 2026.
Tandem Diabetes Care made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1532 holding.
162 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.